Bioequivalence (BE) studies are a critical component of modern drug development and regulatory evaluation. They are conducted to compare the rate and extent of absorption between a test product and a reference product, thereby demonstrating comparable bioavailability and therapeutic performance in vivo. BE studies are essential for generic drug development, formulation optimization, lifecycle management, and international registration.
Due to varying regulatory requirements across different countries and regions, BE projects require comprehensive planning and scientific evaluation. Factors such as drug characteristics, dosage form complexity, pharmacokinetic variability, patient population, and study design strategies must all be carefully considered to ensure reliable and compliant outcomes.
With extensive experience across more than 100 BE projects, Protheragen provides integrated bioequivalence services to support pharmaceutical companies from protocol design through regulatory submission, helping accelerate product development and global market access.
Protheragen offers comprehensive bioequivalence study support throughout the entire development lifecycle, including:
Our team designs customized BE strategies based on the specific characteristics of each product and regulatory expectations. We support:
Standard BE Studies
|
Advanced PK & Statistical Approaches
|
Protheragen has substantial experience in managing complex and challenging BE projects, including but not limited to:
| Special Project Type | Key Challenges | Our Expertise |
|---|---|---|
| High Variability Drugs | Large intra-subject variability | Replicate designs and scaled BE methods |
| Narrow Therapeutic Index (NTI) Drugs | Strict acceptance criteria | Precision-focused study design |
| Long Half-life Drugs | Long washout periods | Optimized scheduling and PK management |
| Endogenous Compounds | Baseline correction complexity | Advanced analytical and statistical strategies |
We support BE studies for a broad range of conventional and complex formulations.
| Dosage Form | Service Highlights |
|---|---|
| Modified-release formulations | PK profile comparison and steady-state evaluation |
| Enteric-coated preparations | Food-effect and dissolution correlation support |
| Soft gelatin capsules | Absorption variability assessment |
| Orally disintegrating tablets (ODT) | Rapid dissolution and administration evaluation |
| Liposomal formulations | Complex bioanalytical and PK characterization |
| Topical/Dermal products | Local delivery and comparative absorption studies |
| Pulmonary/Inhalation products | Device-use and pulmonary delivery assessment |
| Fixed-dose combinations (FDC) | Multi-component PK analysis |
Protheragen supports BE projects intended for global regulatory submissions and international market entry. Our team is familiar with regional guidelines and technical expectations for:
| Region | Regulatory Considerations |
|---|---|
| United States | FDA BE guidance and ANDA requirements |
| European Union | EMA bioequivalence guidelines |
| Australia | TGA registration support |
| ASEAN Countries | Regional harmonization and local requirements |
We assist clients in preparing compliant study documentation and submission-ready reports aligned with international standards.
1. Extensive Project Experience
More than 10 years of experience in bioequivalence and clinical research services.
2. Scientific & Regulatory Expertise
Experienced multidisciplinary teams covering clinical pharmacology, PK analysis, statistics, operations, and regulatory affairs.
3. Flexible Study Solutions
Customized study designs tailored to product characteristics and regional regulatory expectations.
4. Global Development Support
Integrated solutions for domestic and international registration pathways.
5. Quality & Compliance
Strict adherence to GCP, GLP, and international regulatory standards to ensure reliable and audit-ready results.
Protheragen is committed to delivering efficient, scientifically rigorous, and regulatory-compliant bioequivalence solutions for pharmaceutical and biotechnology companies worldwide. Contact us to discuss your BE project requirements and discover how our expertise can support your product development and global registration goals.